These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11715146)

  • 21. Ecstasy and cocaine: patterns of use among prime age individuals in Amsterdam.
    van Ours JC
    Addict Behav; 2005 Aug; 30(7):1468-73. PubMed ID: 16022944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy.
    Curran HV; Robjant K
    J Psychopharmacol; 2006 May; 20(3):425-31. PubMed ID: 16574717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C; Fisk JE; Wareing M; Murphy P
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute, transient urinary retention from combined ecstasy and methamphetamine use.
    Delgado JH; Caruso MJ; Waksman JC; Honigman B; Stillman D
    J Emerg Med; 2004 Feb; 26(2):173-5. PubMed ID: 14980339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine abuse and "meth mouth".
    Rhodus NL; Little JW
    Northwest Dent; 2005; 84(5):29, 31, 33-7. PubMed ID: 16317979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Massive intracerebral hematoma and extradural hematoma in amphetamine abuse.
    Agaba EA; Lynch RM; Baskaran A; Jackson T
    Am J Emerg Med; 2002 Jan; 20(1):55-7. PubMed ID: 11781916
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
    Casco C; Forcella M; Beretta G; Grieco A; Campana G
    Addict Biol; 2005 Jun; 10(2):187-95. PubMed ID: 16191672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
    Verheyden SL; Henry JA; Curran HV
    Hum Psychopharmacol; 2003 Oct; 18(7):507-17. PubMed ID: 14533132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tale of two Es.
    Nutt DJ
    J Psychopharmacol; 2006 May; 20(3):315-7. PubMed ID: 16574702
    [No Abstract]   [Full Text] [Related]  

  • 33. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.
    de Win MM; Schilt T; Reneman L; Vervaeke H; Jager G; Dijkink S; Booij J; van den Brink W
    J Psychopharmacol; 2006 Mar; 20(2):226-35. PubMed ID: 16510480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
    Lyvers M
    Drug Alcohol Rev; 2006 May; 25(3):269-76. PubMed ID: 16753651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task.
    Roberts GM; Nestor L; Garavan H
    Brain Res; 2009 Oct; 1292():71-81. PubMed ID: 19631624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecstasy-related deficits in the updating component of executive processes.
    Montgomery C; Fisk JE
    Hum Psychopharmacol; 2008 Aug; 23(6):495-511. PubMed ID: 18512857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
    Chrostek Maj J; Kroch S; Kamenczak A; Polewka A; Szerszeń-Motyka J
    Przegl Lek; 2004; 61(4):317-9. PubMed ID: 15521592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding ecstasy.
    Outslay MG
    JAAPA; 2006 Jul; 19(7):42-7. PubMed ID: 16869151
    [No Abstract]   [Full Text] [Related]  

  • 40. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.